Arcus Biosciences Inc [NYSE: RCUS] traded at a low on Wednesday, posting a -2.10 loss after which it closed the day’ session at $14.92.
The results of the trading session contributed to over 389933 shares changing hands. Over the past one week, the price volatility of Arcus Biosciences Inc stands at 4.16% while the volatility over the past one month is 4.80%.
The market cap for RCUS stock reached $1.37 billion, with 91.50 million shares outstanding and 49.26 million shares in the current float. Compared to the average trading volume of 757.37K shares, RCUS reached a trading volume of 389933 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Arcus Biosciences Inc [RCUS]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RCUS shares is $32.80 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RCUS stock is a recommendation set at 1.64. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Arcus Biosciences Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on October 21, 2024. While these analysts kept the previous recommendation, Wells Fargo raised their target price to Overweight. The new note on the price target was released on October 08, 2024, representing the official price target for Arcus Biosciences Inc stock. Previously, the target price had yet another raise to $33, while BofA Securities analysts kept a Neutral rating on RCUS stock.
The Average True Range (ATR) for Arcus Biosciences Inc is set at 0.77, with the Price to Sales ratio for RCUS stock in the period of the last 12 months amounting to 5.19. The Price to Book ratio for the last quarter was 2.42, with the Price to Cash per share for the same quarter was set at 11.90.
How has RCUS stock performed recently?
Arcus Biosciences Inc [RCUS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.20. With this latest performance, RCUS shares dropped by -13.71% in over the last four-week period, additionally plugging by 7.03% over the last 6 months – not to mention a drop of -20.55% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RCUS stock in for the last two-week period is set at 41.71, with the RSI for the last a single of trading hit 39.15, and the three-weeks RSI is set at 43.68 for Arcus Biosciences Inc [RCUS]. The present Moving Average for the last 50 days of trading for this stock 15.88, while it was recorded at 15.04 for the last single week of trading, and 16.08 for the last 200 days.
Arcus Biosciences Inc [RCUS]: Deeper insight into the fundamentals
Arcus Biosciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.23 and a Current Ratio set at 5.23.
Earnings analysis for Arcus Biosciences Inc [RCUS]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for RCUS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Arcus Biosciences Inc go to 7.80%.
Insider trade positions for Arcus Biosciences Inc [RCUS]
There are presently around $59.67%, or 97.64%% of RCUS stock, in the hands of institutional investors. The top three institutional holders of RCUS stocks are: BLACKROCK INC. with ownership of 9.76 million shares, which is approximately 11.3261%. VANGUARD GROUP INC, holding 5.26 million shares of the stock with an approximate value of $$80.07 million in RCUS stocks shares; and VANGUARD GROUP INC, currently with $$64.65 million in RCUS stock with ownership which is approximately 4.9249%.
